Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Natalizumab Therapy for Multiple Sclerosis.
Reverse causality behind the association between reproductive history and MS.
Schwann cells in therapy of spinal cord injuries.
ApoTransferrin: Dual Role on Adult Subventricular Zone-Derived Neurospheres.
Ethical challenges in paediatric clinical trials in multiple sclerosis.
Human Aquaporin 4281-300 Is the Immunodominant Linear Determinant in the Context of HLA-DRB1*03:01: Relevance for Diagnosing and Monitoring Patients With Neuromyelitis OpticaImmunodominant Linear Determinants of hAQP4.
Sacral nerve stimulation for neurogenic bladder.
Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume.
Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations.
Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: Biochemical, pharmacological and toxicological implications.
Insights into TREM2 biology by network analysis of human brain gene expression data.
[Change of treatment in patients with multiple sclerosis and its consequences in clinical practice].
Mice devoid of tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis.
Immunological differences between classical phenothypes of multiple sclerosis.
Immunosuppressive treatments in multiple sclerosis.
Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.
Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Myelination at a glance.
Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions.
Interleukin 18 gene polymorphism is a risk factor for multiple sclerosis.
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
Guillain-Barré syndrome: subtypes and predictors of outcome from India.
Viruses and Multiple Sclerosis.
Comparative validity of accelerometer based measures of physical activity for people with multiple sclerosis.
Pages
« first
‹ previous
…
257
258
259
260
261
262
263
264
265
…
next ›
last »